ACQUISITION OF GROUP N 1 NERVOUS SYSTEM MEDICINES FOR MANTA GENERAL HOSPITAL

This tender, identified by code SIE-HGM-2025-008-74622, is for the acquisition of medicines classified under Group N 1, pertaining to the nervous system, for the Manta General Hospital (HOSPITAL GENERAL MANTA). The procurement method is an Electronic Reverse Auction. The specific item detailed is Remifentanil, a parenteral solid formulation of 5 mg, supplied in vials, with a required quantity of 1,500 units. The estimated cost for this acquisition is USD 477,778.60. This procurement is vital for the hospital's ability to manage pain and provide anesthesia or sedation for patients undergoing medical procedures or suffering from severe pain conditions related to the nervous system. Remifentanil is a potent opioid analgesic used in critical care and surgical settings. Ensuring a consistent supply of such specialized medications is essential for patient safety and effective clinical management. The tender aims to secure these critical nervous system medications through a competitive bidding process.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.